BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkamp G, Heijerman HG, Robberecht E, Döring G. Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros 2002;1:51-75. [PMID: 15463811 DOI: 10.1016/s1569-1993(02)00032-2] [Cited by in Crossref: 295] [Cited by in F6Publishing: 45] [Article Influence: 16.4] [Reference Citation Analysis]
Number Citing Articles
1 Neri LCL, Bergamaschi DP, Silva Filho LVRFD. EVALUATION OF NUTRITIONAL STATUS IN PATIENTS WITH CYSTIC FIBROSIS ACCORDING TO AGE GROUP. Rev Paul Pediatr 2019;37:58-64. [PMID: 30110111 DOI: 10.1590/1984-0462/;2019;37;1;00007] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Parisi GF, Cutello S, Di Dio G, Rotolo N, La Rosa M, Leonardi S. Phenotypic expression of the p.Leu1077Pro CFTR mutation in Sicilian cystic fibrosis patients. BMC Res Notes 2013;6:461. [PMID: 24225052 DOI: 10.1186/1756-0500-6-461] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
3 Castellani C, Cuppens H, Macek M, Cassiman JJ, Kerem E, Durie P, Tullis E, Assael BM, Bombieri C, Brown A, Casals T, Claustres M, Cutting GR, Dequeker E, Dodge J, Doull I, Farrell P, Ferec C, Girodon E, Johannesson M, Kerem B, Knowles M, Munck A, Pignatti PF, Radojkovic D, Rizzotti P, Schwarz M, Stuhrmann M, Tzetis M, Zielenski J, Elborn JS. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros. 2008;7:179-196. [PMID: 18456578 DOI: 10.1016/j.jcf.2008.03.009] [Cited by in Crossref: 370] [Cited by in F6Publishing: 315] [Article Influence: 26.4] [Reference Citation Analysis]
4 Poustie VJ, Russell JE, Watling RM, Ashby D, Smyth RL. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ. 2006;332:632-636. [PMID: 16467348 DOI: 10.1136/bmj.38737.600880.ae] [Cited by in Crossref: 50] [Cited by in F6Publishing: 13] [Article Influence: 3.1] [Reference Citation Analysis]
5 Fuster CO, Fuster GO, Galindo AD, Galo AP, Verdugo JM, Lozano FM. [Analysis of energy expenditure in adults with cystic fibrosis: comparison of indirect calorimetry and prediction equations]. Arch Bronconeumol 2007;43:366-72. [PMID: 17663888 DOI: 10.1016/s1579-2129(07)60087-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Hortencio TD, Nogueira RJ, Marson FA, Hessel G, Ribeiro JD, Ribeiro AF. [Factors impacting the growth and nutritional status of cystic fibrosis patients younger than 10 years of age who did not undergo neonatal screening]. Rev Paul Pediatr 2015;33:3-11. [PMID: 25681074 DOI: 10.1016/j.rpped.2014.11.004] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
7 Minasian CC, Sriskandan S, Balfour-Lynn IM, Bush A. Cystic fibrosis presenting with haematological abnormalities. Clin Lab Haematol 2006;28:423-6. [PMID: 17105498 DOI: 10.1111/j.1365-2257.2006.00822.x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
8 Yang B, Han K, Kim SH, Lee DH, Park SH, Yoo JE, Shin DW, Choi H, Lee H. Being Underweight Increases the Risk of Non-Cystic Fibrosis Bronchiectasis in the Young Population: A Nationwide Population-Based Study. Nutrients 2021;13:3206. [PMID: 34579084 DOI: 10.3390/nu13093206] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 van der Doef HP, Kokke FT, van der Ent CK, Houwen RH. Intestinal obstruction syndromes in cystic fibrosis: meconium ileus, distal intestinal obstruction syndrome, and constipation. Curr Gastroenterol Rep. 2011;13:265-270. [PMID: 21384135 DOI: 10.1007/s11894-011-0185-9] [Cited by in Crossref: 78] [Cited by in F6Publishing: 57] [Article Influence: 7.1] [Reference Citation Analysis]
10 Drzymała-Czyż S, Krzyżanowska P, Koletzko B, Nowak J, Miśkiewicz-Chotnicka A, Moczko JA, Lisowska A, Walkowiak J. Determinants of Serum Glycerophospholipid Fatty Acids in Cystic Fibrosis. Int J Mol Sci 2017;18:E185. [PMID: 28106773 DOI: 10.3390/ijms18010185] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
11 Davies JC, Cunningham S, Harris WT, Lapey A, Regelmann WE, Sawicki GS, Southern KW, Robertson S, Green Y, Cooke J, Rosenfeld M; KIWI Study Group. Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study. Lancet Respir Med 2016;4:107-15. [PMID: 26803277 DOI: 10.1016/S2213-2600(15)00545-7] [Cited by in Crossref: 176] [Cited by in F6Publishing: 59] [Article Influence: 29.3] [Reference Citation Analysis]
12 Jagannath VA, Thaker V, Chang AB, Price AI. Vitamin K supplementation for cystic fibrosis. Cochrane Database Syst Rev 2020;6:CD008482. [PMID: 32497260 DOI: 10.1002/14651858.CD008482.pub6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Zhang Z, Lindstrom MJ, Lai HJ. Pubertal height velocity and associations with prepubertal and adult heights in cystic fibrosis. J Pediatr 2013;163:376-82. [PMID: 23535012 DOI: 10.1016/j.jpeds.2013.02.026] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
14 Kalnins D, Wilschanski M. Maintenance of nutritional status in patients with cystic fibrosis: new and emerging therapies. Drug Des Devel Ther 2012;6:151-61. [PMID: 22787388 DOI: 10.2147/DDDT.S9258] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
15 Savage E, Callery P. Weight and energy: parents' and children's perspectives on managing cystic fibrosis diet. Arch Dis Child 2005;90:249-52. [PMID: 15723908 DOI: 10.1136/adc.2004.056804] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
16 Wolfe SP, Wilschanski M. Nutrition in CF — Two new important guidelines. Journal of Cystic Fibrosis 2016;15:708-9. [DOI: 10.1016/j.jcf.2016.10.004] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
17 Chaves CRMM, Cunha ALP. Avaliação e recomendações nutricionais para crianças e adolescentes com fibrose cística. Rev paul pediatr 2012;30:131-8. [DOI: 10.1590/s0103-05822012000100019] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Thaker V, Carter B, Putman M. Recombinant growth hormone therapy for cystic fibrosis in children and young adults. Cochrane Database Syst Rev 2018;12:CD008901. [PMID: 30557452 DOI: 10.1002/14651858.CD008901.pub4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
19 Mangas-Sánchez C, Garriga-García M, Serrano-Nieto MJ, García-Romero R, Álvarez-Beltrán M, Crehuá-Gaudiza E, Muñoz-Codoceo R, Suárez-Cortina L, Vicente-Santamaría S, Martínez-Costa C, Díaz-Martin JJ, Bousoño-García C, González-Jiménez D. Vitamin D Status in Pediatric and Young Adult Cystic Fibrosis Patients. Are the New Recommendations Effective? Nutrients 2021;13:4413. [PMID: 34959965 DOI: 10.3390/nu13124413] [Reference Citation Analysis]
20 Michel SH, Mallowe A. Nutrition Management of the Infant Identified With Cystic Fibrosis. Topics in Clinical Nutrition 2012;27:260-9. [DOI: 10.1097/tin.0b013e3182625b3c] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Garriga M, Horrisberger A, Lamas A, Ruiz de Valbuena M, Suárez L. Evaluation of the usefulness of a standard multivitamin supplement designed for patients with cystic fibrosis. Anales de Pediatría (English Edition) 2015;83:277-9. [DOI: 10.1016/j.anpede.2015.08.006] [Reference Citation Analysis]
22 Calvo-Lerma J, Boon M, Hulst J, Colombo C, Asseiceira I, Garriga M, Masip E, Claes I, Bulfamante A, Janssens HM, Roca M, Vicente S, Fornés V, Zazzeron L, van Schijndel B, Woodcock S, Pereira L, de Boeck K, Ribes-Koninckx C. Change in Nutrient and Dietary Intake in European Children with Cystic Fibrosis after a 6-Month Intervention with a Self-Management mHealth Tool. Nutrients 2021;13:1801. [PMID: 34073260 DOI: 10.3390/nu13061801] [Reference Citation Analysis]
23 Neri LCL, Simon MISDS, Ambrósio VLS, Barbosa E, Garcia MF, Mauri JF, Guirau RR, Neves MA, Cunha CAP, Nogueira MC, Alves ACDC, Gurmini J, Servidoni MF, Epifanio M, Athanazio R; Grupo de Trabalho das Diretrizes Brasileiras de Nutrição em Fibrose Cística. Brazilian Guidelines for Nutrition in Cystic Fibrosis. Einstein (Sao Paulo) 2022;20:eRW5686. [PMID: 35384985 DOI: 10.31744/einstein_journal/2022RW5686] [Reference Citation Analysis]
24 Portal C, Gouyer V, Léonard R, Husson MO, Gottrand F, Desseyn JL. Long-term dietary (n-3) polyunsaturated fatty acids show benefits to the lungs of Cftr F508del mice. PLoS One 2018;13:e0197808. [PMID: 29856782 DOI: 10.1371/journal.pone.0197808] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
25 Smyth RL, Rayner O. Oral calorie supplements for cystic fibrosis. Cochrane Database Syst Rev 2017;5:CD000406. [PMID: 28470972 DOI: 10.1002/14651858.CD000406.pub5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
26 Choe YJ, Ko JS, Seo JK, Han JJ, Shim JO, Koh YY, Lee R, Ki CS, Kim JW, Kim JH. Novel CFTR mutations in a Korean infant with cystic fibrosis and pancreatic insufficiency. J Korean Med Sci 2010;25:163-5. [PMID: 20052365 DOI: 10.3346/jkms.2010.25.1.163] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
27 Jagannath VA, Thaker V, Chang AB, Price AI. Vitamin K supplementation for cystic fibrosis. Cochrane Database Syst Rev 2017;8:CD008482. [PMID: 28829533 DOI: 10.1002/14651858.CD008482.pub5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
28 Mantzios M, Egan H. Mindfulness Training May Enhance the Psychological Well-Being of People with Cystic Fibrosis. Mindfulness 2016;7:781-4. [DOI: 10.1007/s12671-015-0462-z] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
29 Strandvik B. Nutrition in Cystic Fibrosis—Some Notes on the Fat Recommendations. Nutrients 2022;14:853. [DOI: 10.3390/nu14040853] [Reference Citation Analysis]
30 Sommerburg O, De Spirt S, Mattern A, Joachim C, Langhans CD, Nesaretnam K, Siems W, Stahl W, Mall MA. Supplementation with red palm oil increases β-carotene and vitamin A blood levels in patients with cystic fibrosis. Mediators Inflamm 2015;2015:817127. [PMID: 25688177 DOI: 10.1155/2015/817127] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
31 Giannakopoulos A, Katelaris A, Noni M, Karakonstantakis T, Kanaka-Gantenbein C, Doudounakis S. Hyperthyrotropinemia in newly diagnosed cystic fibrosis patients with pancreatic insufficiency reversed by enzyme therapy. Eur J Pediatr 2018;177:775-9. [PMID: 29487998 DOI: 10.1007/s00431-018-3120-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Morin C, Cantin AM, Vézina FA, Fortin S. The Efficacy of MAG-DHA for Correcting AA/DHA Imbalance of Cystic Fibrosis Patients. Mar Drugs 2018;16:E184. [PMID: 29861448 DOI: 10.3390/md16060184] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
33 Kondratyeva E, Bukharova T, Efremova A, Melyanovskaya Y, Bulatenko N, Davydenko K, Filatova A, Skoblov M, Krasovsky S, Petrova N, Polyakov A, Adyan T, Amelina E, Shadrina V, Zhekaite E, Zodbinova A, Chernyak A, Zinchenko R, Kutsev S, Goldshtein D. Health Characteristics of Patients with Cystic Fibrosis whose Genotype Includes a Variant of the Nucleotide Sequence c.3140-16T>A and Functional Analysis of this Variant. Genes (Basel) 2021;12:837. [PMID: 34071719 DOI: 10.3390/genes12060837] [Reference Citation Analysis]
34 Johnson CD, Arbuckle R, Bonner N, Connett G, Dominguez-Munoz E, Levy P, Staab D, Williamson N, Lerch MM. Qualitative Assessment of the Symptoms and Impact of Pancreatic Exocrine Insufficiency (PEI) to Inform the Development of a Patient-Reported Outcome (PRO) Instrument. Patient 2017;10:615-28. [PMID: 28332032 DOI: 10.1007/s40271-017-0233-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
35 Jagannath VA, Fedorowicz Z, Thaker V, Chang AB. Vitamin K supplementation for cystic fibrosis. Cochrane Database Syst Rev 2015;1:CD008482. [PMID: 25879106 DOI: 10.1002/14651858.CD008482.pub4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
36 Mößeler A, Gregory PC, Loock H, Beyerbach M, Kamphues J. Endogenous praecaecal and total tract losses of nitrogen in pancreatic duct-ligated minipigs. Arch Anim Nutr 2015;69:98-112. [PMID: 25690557 DOI: 10.1080/1745039X.2015.1009612] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
37 Lee MJ, Alvarez JA, Smith EM, Killilea DW, Chmiel JF, Joseph PM, Grossmann RE, Gaggar A, Ziegler TR, Tangpricha V; Vitamin D for Enhancing the Immune System in Cystic Fibrosis Investigators. Changes in Mineral Micronutrient Status During and After Pulmonary Exacerbation in Adults With Cystic Fibrosis. Nutr Clin Pract 2015;30:838-43. [PMID: 26078287 DOI: 10.1177/0884533615589991] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
38 Shei RJ, Mackintosh KA, Peabody Lever JE, McNarry MA, Krick S. Exercise Physiology Across the Lifespan in Cystic Fibrosis. Front Physiol 2019;10:1382. [PMID: 31780953 DOI: 10.3389/fphys.2019.01382] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Van Iterson EH, Wheatley CM, Baker SE, Morgan WJ, Snyder EM. The relationship between cardiac hemodynamics and exercise tolerance in cystic fibrosis. Heart Lung 2016;45:283-90. [PMID: 27045901 DOI: 10.1016/j.hrtlng.2016.03.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
40 Wouthuyzen-Bakker M, Bijvelds MJ, de Jonge HR, De Lisle RC, Burgerhof JG, Verkade HJ. Effect of antibiotic treatment on fat absorption in mice with cystic fibrosis. Pediatr Res 2012;71:4-12. [PMID: 22289844 DOI: 10.1038/pr.2011.4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
41 Moen IE, Nilsson K, Andersson A, Fagerland MW, Fluge G, Hollsing A, Gilljam M, Mared L, Pressler T, Santi H, Storrøsten OT, Hjelte L. Dietary intake and nutritional status in a Scandinavian adult cystic fibrosis-population compared with recommendations. Food Nutr Res 2011;55. [PMID: 22110412 DOI: 10.3402/fnr.v55i0.7561] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
42 Shandro BM, Nagarajah R, Poullis A. Challenges in the management of pancreatic exocrine insufficiency. World J Gastrointest Pharmacol Ther 2018; 9(5): 39-46 [PMID: 30397535 DOI: 10.4292/wjgpt.v9.i5.39] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
43 Okebukola PO, Kansra S, Barrett J. Vitamin E supplementation in people with cystic fibrosis. Cochrane Database Syst Rev 2017;3:CD009422. [PMID: 28262916 DOI: 10.1002/14651858.CD009422.pub3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
44 Sundell MDOT, Meneses DG, Ribeiro AF, Pinto EALC, Hessel G. Kwashiorkor e distúrbio de coagulação: apresentação atípica de fibrose cística. Rev paul pediatr 2012;30:139-43. [DOI: 10.1590/s0103-05822012000100020] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
45 Adriaanse MP, van der Sande LJ, van den Neucker AM, Menheere PP, Dompeling E, Buurman WA, Vreugdenhil AC. Evidence for a Cystic Fibrosis Enteropathy. PLoS One 2015;10:e0138062. [PMID: 26484665 DOI: 10.1371/journal.pone.0138062] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
46 Nagy R, Gede N, Ocskay K, Dobai BM, Abada A, Vereczkei Z, Pázmány P, Kató D, Hegyi P, Párniczky A. Association of Body Mass Index With Clinical Outcomes in Patients With Cystic Fibrosis: A Systematic Review and Meta-analysis. JAMA Netw Open 2022;5:e220740. [PMID: 35254432 DOI: 10.1001/jamanetworkopen.2022.0740] [Reference Citation Analysis]
47 Thaker V, Haagensen AL, Carter B, Fedorowicz Z, Houston BW. Recombinant growth hormone therapy for cystic fibrosis in children and young adults. Cochrane Database Syst Rev 2013;:CD008901. [PMID: 23737090 DOI: 10.1002/14651858.CD008901.pub2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
48 Gavioli EM, Pao K, Harrington M. A retrospective evaluation of vitamin K for hemoptysis in adult cystic fibrosis patients. Hosp Pract (1995) 2021;49:262-5. [PMID: 33726579 DOI: 10.1080/21548331.2021.1905413] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Athanazio RA, Silva Filho LVRF, Vergara AA, Ribeiro AF, Riedi CA, Procianoy EDFA, Adde FV, Reis FJC, Ribeiro JD, Torres LA, Fuccio MB, Epifanio M, Firmida MC, Damaceno N, Ludwig-Neto N, Maróstica PJC, Rached SZ, Melo SFO; Grupo de Trabalho das Diretrizes Brasileiras de Diagnóstico e Tratamento da Fibrose Cística. Brazilian guidelines for the diagnosis and treatment of cystic fibrosis. J Bras Pneumol 2017;43:219-45. [PMID: 28746534 DOI: 10.1590/S1806-37562017000000065] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
50 Layer P, Kashirskaya N, Gubergrits N. Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency. World J Gastroenterol 2019; 25(20): 2430-2441 [PMID: 31171887 DOI: 10.3748/wjg.v25.i20.2430] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
51 Nakajima K, Oshida H, Muneyuki T, Kakei M. Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency. Core Evid. 2012;7:77-91. [PMID: 22936895 DOI: 10.2147/ce.s26705] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
52 Morton A. Why bother to take vitamins? J R Soc Med 2011;104 Suppl 1:S19-29. [PMID: 21719888 DOI: 10.1258/jrsm.2011.s11104] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
53 Hirche TO, Bradley J, d'Alquen D, De Boeck K, Dembski B, Elborn JS, Gleiber W, Lais C, Malfroot A, Wagner TO; European Centres of Reference Network for Cystic Fibrosis (ECORN-CF) Study Group. Travelling with cystic fibrosis: recommendations for patients and care team members. J Cyst Fibros 2010;9:385-99. [PMID: 20850392 DOI: 10.1016/j.jcf.2010.08.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
54 Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, Spear SL, Michel SH, Parad RB, White TB, Farrell PM, Marshall BC, Accurso FJ; Cystic Fibrosis Foundation. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr 2009;155:S73-93. [PMID: 19914445 DOI: 10.1016/j.jpeds.2009.09.001] [Cited by in Crossref: 223] [Cited by in F6Publishing: 170] [Article Influence: 18.6] [Reference Citation Analysis]
55 Siwamogsatham O, Dong W, Binongo JN, Chowdhury R, Alvarez JA, Feinman SJ, Enders J, Tangpricha V. Relationship Between Fat-Soluble Vitamin Supplementation and Blood Concentrations in Adolescent and Adult Patients With Cystic Fibrosis. Nutr Clin Pract 2014;29:491-7. [PMID: 24743047 DOI: 10.1177/0884533614530170] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
56 Sands D, Umławska W, Zielińska A. A cross-sectional study of growth, nutritional status and body proportions in children and adolescents at a medical center specializing in the treatment of cystic fibrosis in Poland. Arch Med Sci 2015;11:155-63. [PMID: 25861303 DOI: 10.5114/aoms.2015.49207] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
57 Krzyżanowska P, Pogorzelski A, Skorupa W, Moczko J, Grebowiec P, Walkowiak J. Exogenous and endogenous determinants of vitamin K status in cystic fibrosis. Sci Rep 2015;5:12000. [PMID: 26160248 DOI: 10.1038/srep12000] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
58 Lai HJ, Shoff SM. Classification of malnutrition in cystic fibrosis: implications for evaluating and benchmarking clinical practice performance. Am J Clin Nutr 2008;88:161-6. [PMID: 18614737 DOI: 10.1093/ajcn/88.1.161] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
59 Schechter MS, Michel S, Liu S, Seo BW, Kapoor M, Khurmi R, Haupt M. Relationship of Initial Pancreatic Enzyme Replacement Therapy Dose With Weight Gain in Infants With Cystic Fibrosis. J Pediatr Gastroenterol Nutr 2018;67:520-6. [PMID: 30052568 DOI: 10.1097/MPG.0000000000002108] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
60 Okebukola PO, Kansra S, Barrett J. Vitamin E supplementation in people with cystic fibrosis. Cochrane Database Syst Rev 2020;9:CD009422. [PMID: 32892350 DOI: 10.1002/14651858.CD009422.pub4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Siwamogsatham O, Alvarez JA, Tangpricha V. Diagnosis and treatment of endocrine comorbidities in patients with cystic fibrosis. Curr Opin Endocrinol Diabetes Obes 2014;21:422-9. [PMID: 25105995 DOI: 10.1097/MED.0000000000000096] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
62 Shlieout G, Koerner A, Maffert M, Forssmann K, Caras S. Administration of CREON® pancrelipase pellets via gastrostomy tube is feasible with no loss of gastric resistance or lipase activity: an in vitro study. Clin Drug Investig. 2011;31:e1-e7. [PMID: 21627335 DOI: 10.2165/11592990-000000000-00000] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
63 Mößeler A, Schmicke M, Höltershinken M, Beyerbach M, Kamphues J. Oral Supplementation with a Special Additive of Retinyl Palmitate and Alpha Tocopherol Reduces Growth Retardation in Young Pancreatic Duct Ligated Pigs Used as a Model for Children Suffering from Exocrine Pancreatic Insufficiency. Int J Mol Sci 2016;17:E1642. [PMID: 27690005 DOI: 10.3390/ijms17101642] [Reference Citation Analysis]
64 Simon MI, Drehmer M, Menna-Barreto SS. Association between nutritional status and dietary intake in patients with cystic fibrosis. J Bras Pneumol 2009;35:966-72. [PMID: 19918628 DOI: 10.1590/s1806-37132009001000004] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
65 Kahre T, Teder M, Panov M, Metspalu A. Severe CF manifestation with anaemia and failure to thrive in a 394delTT homozygous patient. J Cyst Fibros 2004;3:58-60. [PMID: 15463888 DOI: 10.1016/j.jcf.2003.12.009] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]